Evaluation of Patiromer in Heart Failure Patients

Part of paid clinical trials in Miami, Florida.

Sponsor
Relypsa, Inc.
Study ID
NCT00868439
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • patiromer — DRUG
    Active investigational drug
  • placebo — DRUG
    placebo

Study Details

The purpose of this study was to assess the effects of patiromer on serum potassium participants with heart failure. This study also assessed the safety and tolerability of patiromer in participants with heart failure.

Key Dates

Start date
Apr 30, 2009
Status verified
May 2021
Primary completion
Nov 30, 2009
Completion
Dec 31, 2009

Study Design

Enrollment
120 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: patiromer
  • Placebo Comparator: placebo

Primary Outcome Measure

Change From Baseline in Serum Potassium to the End of the 28-day Treatment Period. [ Time Frame: Baseline and Day 28 ]

Locations (9)

FacilityCityStateZIPSite coordinators
Investigator Site 029MiamiFlorida33176-
Investigator Site 031Port CharlotteFlorida33952-
Investigator Site 009PeoriaIllinois61606-
Investigator Site 018MinneapolisMinnesota55417-
Investigator Site 020BuffaloNew York14215-
Investigator Site 005NorthportNew York11768-
Investigator Site 022ColumbusOhio43210-
Investigator Site 001DallasTexas75216-
Investigator Site 019Salt Lake CityUtah84124-

Find similar trials in Miami, FL

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
Investigator· Miami, FLInvestigator· Port Charlotte, FLInvestigator· Peoria, ILInvestigator· Minneapolis, MNInvestigator· Buffalo, NYInvestigator· Northport, NY

Related Studies